Brooke Bumpers has spent her entire legal career working with healthcare and life sciences organizations, helping them understand federal and state regulatory and legislative issues to resolve their problems. She has comprehensive knowledge of the regulation of clinical laboratories and medical device companies, including Clinical Laboratory Improvement Amendments (CLIA) and state regulation, as well as in the areas of hospice and palliative care and end-of-life issues.
Brooke enjoys variety in her practice, with a background in the regulation of human tissue, including organ donation, reproductive medicine, telemedicine and digital health, and healthcare reform, including Medicare's initiatives to transition from fee for service to performance-based payment systems.
Brooke especially enjoys learning about her clients' business and policy goals and helping them achieve them. Whether that involves advising on compliance with existing laws and regulations, working to change them through legislation, or advocating with government agencies, she is up for the challenge. Brooke takes pride in maintaining long-term relationships with clients and helping them with a wide range of issues affecting their industry, including obtaining coding, coverage, and reimbursement for a new lab test; developing and implementing a legislative strategy; or drafting comments on regulatory changes.
Her interest in all things health-related runs deep. Before joining Hogan Lovells in 1994, Brooke worked in the health practice group of a California-based law firm. Prior to attending law school, she worked on health policy issues for a state regulatory agency and a statewide healthcare provider. She chose to attend Georgetown Law School for the wide variety of health-related and regulatory courses offered, and because it was located in Washington, D.C., where she could get a close-up view of the laws and policies being made.
Counsel to the National Hospice and Palliative Care Organization, working on regulatory and legislative issues affecting patients and hospices.
Advises small and national clinical laboratories on federal and state requirements and regulatory due diligence related to lab sales and purchases.
Help clients with proposed changes to implement healthcare reform provisions under the Affordable Care Act.
Advise the American Society for Reproductive Medicine on infertility coverage and regulation of human tissue and stem cell research.
Determine state licensure and other regulatory requirements for the provision of telemedicine services.
Latest thinking and events
Hogan Lovells Events
4 August 2016
04 August 2016